Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-30T02:31:31.951Z Has data issue: false hasContentIssue false

30 - Extrahepatic Biliary Cancer: High Dose Rate Brachytherapy and Photodynamic Therapy

from PART III - ORGAN-SPECIFIC CANCERS

Published online by Cambridge University Press:  18 May 2010

Eric T. Shinohara
Affiliation:
Clinical Resident, University of Pennsylvania Philadelphia, PA
James M. Metz
Affiliation:
Assistant Professor of Radiation Oncology Abramson Cancer Center, University of Pennsylvania Philadelphia, PA
Jean-François H. Geschwind
Affiliation:
The Johns Hopkins University School of Medicine
Michael C. Soulen
Affiliation:
University of Pennsylvania School of Medicine
Get access

Summary

CAUSES OF MALIGNANT OBSTRUCTIVE JAUNDICE

Various types of malignancies, including pancreatic cancer, cholangiocarcinoma, hepatocellular carcinoma, gallbladder carcinoma and metastatic disease, can cause malignant obstruction of the biliary ducts. Cholangiocarcinomas represent approximately 3% of all gastrointestinal cancers (1). It was estimated that approximately 18,500 primary liver cancers would be diagnosed in the United States in 2006 (2) and of these, approximately 15% would be intrahepatic cholangiocarcinomas (3). An estimated 4,600 cases of extrahepatic cholangiocarcinoma were diagnosed in 2007 per estimates from the American Cancer Society. Risk factors include primary sclerosing cholangitis, ulcerative cholitis, choledochal cysts and biliary infections, such as in typhoid carriers. Chemical exposures to nitrosamines, dioxin, asbestos and polychlorinated biphenyls have also been linked to cholangiocarcinoma. Cholangiocarcinomas are usually adenocarcinomas (95% of the time) but rarely are found to be cystadenocarcinomas, hemangioendotheliomas or mucoepidermoid carcinomas. Patients commonly present with right upper quadrant pain, pruritis, anorexia, malaise and weight loss. Up to 30% of patients may present with cholangitis. Elevated liver enzymes, alkaline phosphate and bilirubin can also be seen. Cholangiocarcinomas are usually discovered on ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) or endoscopic retrograde cholangiopancreatography (ERCP). Percutaneous transhepatic cholangiography and laparoscopy can also be used for diagnosis. If the cholangiocarcinoma appears resectable, a Whipple resection or partial hepatectomy can be attempted; with complete resection, 5-year survival rates of up to 25% are seen. Palliative surgery with a biliary bypass can be done in the event that resection is not possible.

Type
Chapter
Information
Interventional Oncology
Principles and Practice
, pp. 346 - 357
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Vauthey, J N and Blumgart, L H. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis, 1994; 14: 109–114.CrossRefGoogle ScholarPubMed
Jemal, A, Siegel, R, Ward, E, et al. Cancer statistics, 2006. CA Cancer J Clin, 2006; 56: 106–130.CrossRefGoogle ScholarPubMed
Patel, T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 2001; 33: 1353–1357.CrossRefGoogle ScholarPubMed
Tompkins, R K, Thomas, D, Wile, A, et al. Prognostic factors in bile duct carcinoma: Analysis of 96 cases. Ann Surg, 1981; 194: 447–457.CrossRefGoogle ScholarPubMed
Erickson, B A and Nag, S. Biliary tree malignancies. J Surg Oncol, 1998; 67: 203–210.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
Andersen, J R, Sorensen, S M, Kruse, A, et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut, 1989; 30: 1132–1135.CrossRefGoogle ScholarPubMed
Freeman, M L and Overby, C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc, 2003; 58: 41–49.CrossRefGoogle ScholarPubMed
Cheng, J L, Bruno, M J, Bergman, J J, et al. Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: Efficacy of self-expandable metallic wallstents. Gastrointest Endosc, 2002; 56: 33–39.CrossRefGoogle ScholarPubMed
Kawamoto, H, Ishii, Y, Nakagawa, M, et al. Analysis of long-term survivors with expandable metallic stent inserted for malignant biliary stenosis. J Hepatobiliary Pancreat Surg, 2003; 10: 95–100.Google ScholarPubMed
Conroy, R M, Shahbazian, A A, Edwards, K C, et al. A new method for treating carcinomatous biliary obstruction with intracatheter radium. Cancer, 1982; 49: 1321–1327.3.0.CO;2-S>CrossRefGoogle ScholarPubMed
Ishii, H, Furuse, J, Nagase, M, et al. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: Results without stenting. Hepatogastroenterology, 2004; 51: 954–957.Google ScholarPubMed
Bowling, T E, Galbraith, S M, Hatfield, A R, et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut, 1996; 39: 852–855.CrossRefGoogle ScholarPubMed
Chan, S Y, Poon, R T, Ng, K K, et al. Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: A case report. World J Gastroenterol, 2005; 11: 3161–3164.CrossRefGoogle ScholarPubMed
Takamura, A, Saito, H, Kamada, T, et al. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys, 2003; 57: 1357–1365.CrossRefGoogle ScholarPubMed
Schoenthaler, R, Phillips, T L, Castro, J, et al. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg, 1994; 219: 267–274.CrossRefGoogle ScholarPubMed
Pilepich, M. (Semin ed.), Hepatic and Biliary Cancer. New York: Marcel Dekker; 1987.Google Scholar
Smoron, G L. Radiation therapy of carcinoma of gallbladder and biliary tract. Cancer, 1977; 40: 1422–1424.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Alden, M E and Mohiuddin, M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys, 1994; 28: 945–951.CrossRefGoogle ScholarPubMed
Kamada, T, Saitou, H, Takamura, A, et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: An analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys, 1996; 34: 767–774.CrossRefGoogle ScholarPubMed
Molt, P, Hopfan, S, Watson, R C, et al. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer, 1986; 57: 536–544.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Buskirk, S J, Gunderson, L L, Schild, S E, et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg, 1992; 215: 125–131.CrossRefGoogle ScholarPubMed
Fields, J N and Emami, B. Carcinoma of the extrahepatic biliary system – results of primary and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys, 1987; 13: 331–338.CrossRefGoogle ScholarPubMed
Gonzalez Gonzalez, D, Gouma, D J, Rauws, E A, et al. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol, 1999; 10 Suppl 4: 215–220.CrossRefGoogle ScholarPubMed
Deodato, F, Clemente, G, Mattiucci, G C, et al. Chemoradiation and brachytherapy in biliary tract carcinoma: Long-term results. Int J Radiat Oncol Biol Phys, 2006; 64: 483–488.CrossRefGoogle ScholarPubMed
Dvorak, J, Jandik, P, Melichar, B, et al. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas. Hepatogastroenterology, 2002; 49: 916–917.Google ScholarPubMed
Kocak, Z, Ozkan, H, Adli, M, et al. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct. Radiat Med, 2005; 23: 200–207.Google ScholarPubMed
Qian, X J, Zhai, R Y, Dai, D K, et al. Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment. World J Gastroenterol, 2006; 12: 331–335.CrossRefGoogle ScholarPubMed
Chen, Y, Wang, X L, Yan, Z P, et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol, 2004; 10: 3506–3510.CrossRefGoogle ScholarPubMed
Bruha, R, Petrtyl, J, Kubecova, M, et al. Intraluminal brachytherapy and self-expandable stents in nonresectable biliary malignancies – the question of long-term palliation. Hepatogastroenterology, 2001; 48: 631–637.Google Scholar
Shin, H S, Seong, J, Kim, W C, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys, 2003; 57: 105–112.CrossRefGoogle ScholarPubMed
Fritz, P, Brambs, H J, Schraube, P, et al. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys, 1994; 29: 855–861.CrossRefGoogle ScholarPubMed
Lu, J J, Bains, Y S, Abdel-Wahab, M, et al. High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma. Cancer J, 2002; 8: 74–78.CrossRefGoogle ScholarPubMed
Nomura, M, Yamakado, K, Nomoto, Y, et al. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer. Int J Oncol, 2002; 20: 325–331.Google ScholarPubMed
Urban, M S, Siegel, J H, Pavlou, W, et al. Treatment of malignant biliary obstruction with a high-dose rate remote afterloading device using a 10 F nasobiliary tube. Gastrointest Endosc, 1990; 36: 292–296.CrossRefGoogle ScholarPubMed
Simmons, D T, Baron, T H, Petersen, B T, et al. A novel endoscopic approach to brachytherapy in the management of hilar cholangiocarcinoma. Am J Gastroenterol, 2006; 101: 1792–1796.CrossRefGoogle ScholarPubMed
Dvorak, J, Petera, J, Papik, Z, et al. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region. Hepatogastroenterology, 2002; 49: 1045–1047.Google ScholarPubMed
Mayo-Smith, W W, Dawson, S L, Mauceri, T, et al. Attenuation effects of biliary endoprostheses on therapeutic radiation. Radiology, 1996; 199: 571–572.CrossRefGoogle ScholarPubMed
Nishioka, N S. Drug, light, and oxygen: A dynamic combination in the clinic. Gastroenterology, 1998; 114: 604–606.CrossRefGoogle ScholarPubMed
Ortner, M A. Photodynamic therapy in cholangiocarcinomas. Best Pract Res Clin Gastroenterol, 2004; 18: 147–154.CrossRefGoogle ScholarPubMed
Harewood, G C, Baron, T H, Rumalla, A, et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol, 2005; 20: 415–420.CrossRefGoogle ScholarPubMed
Ortner, M A, Liebetruth, J, Schreiber, S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology, 1998; 114: 536–542.CrossRefGoogle ScholarPubMed
Ortner, M E, Caca, K, Berr, F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study. Gastroenterology, 2003; 125: 1355–1363.CrossRefGoogle ScholarPubMed
Zoepf, T, Jakobs, R, Arnold, J C, et al. Palliation of nonresectable bile duct cancer: Improved survival after photodynamic therapy. Am J Gastroenterol, 2005; 100: 2426–2430.CrossRefGoogle ScholarPubMed
Berr, F, Wiedmann, M, Tannapfel, A, et al. Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival. Hepatology, 2000; 31: 291–298.CrossRefGoogle ScholarPubMed
Wiedmann, M, Berr, F, Schiefke, I, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc, 2004; 60: 68–75.CrossRefGoogle ScholarPubMed
Nanashima, A, Yamaguchi, H, Shibasaki, S, et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: A preliminary study. J Gastroenterol, 2004; 39: 1095–1101.CrossRefGoogle ScholarPubMed
Wiedmann, M, Caca, K, Berr, F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: A phase II pilot study. Cancer, 2003; 97: 2783–2790.CrossRefGoogle ScholarPubMed
Witzigmann, H, Berr, F, Ringel, U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: Palliative photodynamic therapy plus stenting is comparable to R1/R2 resection. Ann Surg, 2006; 244: 230–239.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×